NICK ZELAYA: The FDA is expected to approve COVID vaccinations for children 12 to 15 as early as this week. NCC News reporter Dan Mallea tells us that CNY parents aren’t exactly getting in line to have their kids vaccinated yet.
DAN MALLEA: Sara Rebeor, mother of three, got the COVID-19 vaccine the first chance she got. When it comes to her kids though, she’s hesitant. Rebeor’s concerns stem from how the vaccine was created.
SARA REBEOR: Ya know they rolled it out to adults, and then they were working on the stuff for the kids so, ya know it’s not like an all-rolled at once so I guess I’m a little concerned there just about what that might mean for them long-term.
MALLEA: Rebeor says even her twelve-year-old is mindful of long-term effects, and because of those possible effects, she isn’t sure when she’ll be ready for her son to get the vaccine.
REBEOR: Ya I mean I think I’d have to just see how it plays out. I don’t know what would do that for me, like I said it’s not really short term affects, it’s the long-term stuff.
MALLEA: Rebeor says a family meeting is incoming to discuss what they’ll do once the vaccine is approved for a younger audience. Dan Mallea, N-C-C News.
SYRACUSE, N.Y. (NCC News) – On Monday, the FDA approved Pfizer’s COVID-19 vaccine to be used by children ages 12 to 15. Sara Rebeor is a Central New York parent and a mother of three, including a 12 year old. She got the COVID-19 vaccine the first chance she got.When it comes to her kids though, she’s hesitant. Rebeor said her concerns stem from how the vaccine was created.
“They rolled it out to adults, and then they were working on the stuff for the kids, so, you know it’s not like an all-rolled at once,” Rebeor said. “So I guess I’m a little concerned there just about what that might mean for them long-term.”
Rebeor also said that even her 12 year old is mindful of long-term COVID-19 vaccine effects, and because of those possible effects, she isn’t sure when she’ll be ready for her son to get the vaccine.
“I think I’d have to just see how it plays out,” Rebeor said. “I don’t know what would do that for me. Like I said, it’s not really short term effects, it’s the long-term stuff. That’s a long time out, so I just don’t know.”
Rebeor said a family meeting is incoming to discuss what they’ll do now that the vaccine is approved for a younger audience.
